首页 › 心血管疾病 › 加利福尼亚州 › Torrance
Torrance CA 心血管疾病临床试验
7项针对 心血管疾病的研究正在 Torrance及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
招募中4 期
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
招募中3 期
- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
招募中3 期
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
招募中3 期
- Clinical Trial Site, Torrance
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
招募中2 期
- Clinical Research Site, Torrance
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
招募中3 期
- Research Site, Torrance
其他城市的 心血管疾病试验
- Boston, MA37 项研究
- New York City, NY33 项研究
- Washington, DC28 项研究
- Houston, TX24 项研究
- Dallas, TX23 项研究
- Atlanta, GA22 项研究
- Cleveland, OH22 项研究
- Chicago, IL21 项研究
- Philadelphia, PA21 项研究
- Pittsburgh, PA20 项研究
- St. Louis, MO20 项研究
- Nashville, TN18 项研究
Torrance的其他研究
- 非小细胞肺癌11 项研究
- 乳腺癌9 项研究
- 超重9 项研究
- 肥胖症9 项研究
- 肺癌7 项研究
- 膀胱癌7 项研究
- 精神分裂症6 项研究
- 心力衰竭5 项研究
- 动脉粥样硬化5 项研究
- 转移性癌症4 项研究
- 结直肠癌4 项研究
- 冠状动脉疾病4 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。